Chickasaw Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Chickasaw Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,000	Closed	-$372K	–	89
2018 Q3	$372K	Hold	6,000	–	–	0.01%	86
2018 Q2	$332K	Buy	6,000 +2,000	+50%	+$108K	0.01%	85
2018 Q1	$253K	Hold	4,000	–	–	0.01%	92
2017 Q4	$245K	Hold	4,000	–	–	0.01%	93
2017 Q3	$255K	Hold	4,000	–	–	0.01%	91
2017 Q2	$223K	Hold	4,000	–	–	﹤0.01%	95
2017 Q1	$218K	Buy	+4,000	New	+$219K	﹤0.01%	93

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Chickasaw Capital Management's BMY Position: Q4 2018 in Review

Chickasaw Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 6,000 shares — an estimated $372K sold.

Chickasaw Capital Management first reported a position in BMY in Q1 2017 and held it in 7 quarters. The position peaked at $372K in Q3 2018. 1,765 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

Chickasaw Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
Chickasaw Capital Management sold 6,000 Bristol-Myers Squibb shares in Q4 2018, an estimated $372K.
Chickasaw Capital Management first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 7 quarters.
Chickasaw Capital Management's Bristol-Myers Squibb position peaked at $372K in Q3 2018.
1,765 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Chickasaw Capital Management's 13F filing for Q4 2018, filed 11 Jan 2019.